Meenakshi Anurag
10PUBLICATIONS
143CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Aug 27, 2025
NF1-depleted ER+ breast cancers are differentially sensitive to CDK4/6 inhibitors.Ze-Yi Zheng, Anran Chen, Eric J Jaehnig
|Aug 08, 2025
Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast Cancer.Nicholas J Neill, Shankha Satpathy, Karsten Krug
|May 23, 2024
PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer.Anran Chen, Beom-Jun Kim, Aparna Mitra
|Aug 17, 2023
Kinase Inhibitor Pulldown Assay Identifies a Chemotherapy Response Signature in Triple-negative Breast Cancer Based on Purine-binding Proteins.Junkai Wang, Alexander B Saltzman, Eric J Jaehnig
|Jul 28, 2023
Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor-positive Breast Cancers for Targeted Treatment.Beom-Jun Kim, Ze-Yi Zheng, Jonathan T Lei
Pageof 2
Frequent Collaborators
10 joint publications
Matthew J Ellis
7 joint publications
Jonathan T Lei
6 joint publications
Beom-Jun Kim
5 joint publications
Lacey E Dobrolecki
5 joint publications
Bora Lim
4 joint publications
Bing Zhang
4 joint publications
George Miles
4 joint publications
Michael T Lewis
4 joint publications
Xuxu Gou
4 joint publications
Matthew V Holt